These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 34933447)

  • 1. Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses.
    White JM; Schiffer JT; Bender Ignacio RA; Xu S; Kainov D; Ianevski A; Aittokallio T; Frieman M; Olinger GG; Polyak SJ
    mBio; 2021 Dec; 12(6):e0334721. PubMed ID: 34933447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2.
    Wagoner J; Herring S; Hsiang TY; Ianevski A; Biering SB; Xu S; Hoffmann M; Pöhlmann S; Gale M; Aittokallio T; Schiffer JT; White JM; Polyak SJ
    Microbiol Spectr; 2022 Oct; 10(5):e0333122. PubMed ID: 36190406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.
    Lisi L; Lacal PM; Barbaccia ML; Graziani G
    Biochem Pharmacol; 2020 Oct; 180():114169. PubMed ID: 32710969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2.
    Yuan S; Yin X; Meng X; Chan JF; Ye ZW; Riva L; Pache L; Chan CC; Lai PM; Chan CC; Poon VK; Lee AC; Matsunaga N; Pu Y; Yuen CK; Cao J; Liang R; Tang K; Sheng L; Du Y; Xu W; Lau CY; Sit KY; Au WK; Wang R; Zhang YY; Tang YD; Clausen TM; Pihl J; Oh J; Sze KH; Zhang AJ; Chu H; Kok KH; Wang D; Cai XH; Esko JD; Hung IF; Li RA; Chen H; Sun H; Jin DY; Sun R; Chanda SK; Yuen KY
    Nature; 2021 May; 593(7859):418-423. PubMed ID: 33727703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human coronaviruses and therapeutic drug discovery.
    Song LG; Xie QX; Lao HL; Lv ZY
    Infect Dis Poverty; 2021 Mar; 10(1):28. PubMed ID: 33726861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
    Krishna G; Pillai VS; Veettil MV
    Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
    Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of SARS-COV-2 Drug Targets and Pharmacological Aspects in Treating the COVID-19.
    Bhavaniramya S; Ramar V; Vishnupriya S; Palaniappan R; Sibiya A; Vaseeharan B
    Curr Mol Pharmacol; 2022; 15(2):393-417. PubMed ID: 34382513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.
    Lee G; Budhathoki S; Lee GY; Oh KJ; Ham YK; Kim YJ; Lim YR; Hoang PT; Lee Y; Lim SW; Kim JM; Cho S; Kim TH; Song JW; Lee S; Kim WK
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of potential therapeutic agents to treat COVID-19.
    Dong X; Tian Z; Shen C; Zhao C
    Biosci Trends; 2020 Nov; 14(5):318-327. PubMed ID: 33100290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.
    Uzunova K; Filipova E; Pavlova V; Vekov T
    Biomed Pharmacother; 2020 Nov; 131():110668. PubMed ID: 32861965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
    Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
    mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus pandemic: treatment and future prevention.
    Lundstrom K
    Future Microbiol; 2020 Oct; 15(15):1507-1521. PubMed ID: 33140657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.
    Jamwal S; Gautam A; Elsworth J; Kumar M; Chawla R; Kumar P
    Life Sci; 2020 Sep; 257():118105. PubMed ID: 32687917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.